Neurocrine Biosciences, Inc. (NBIX)
NASDAQ: NBIX · Real-Time Price · USD
146.23
-5.60 (-3.69%)
At close: Sep 18, 2026, 4:00 PM EDT
146.63
+0.40 (0.27%)
After-hours: Sep 18, 2026, 7:55 PM EDT
Neurocrine Biosciences Market Cap
Neurocrine Biosciences has a market cap or net worth of $14.86 billion as of September 18, 2026. Its market cap has increased by 5.00% in one year.
Market Cap
14.86B
Enterprise Value
14.94B
1-Year Change
5.00%
Ranking
Category
Stock Price
$146.23
ChartMarket Cap Chart
Since December 1, 1998, Neurocrine Biosciences's market cap has increased from $124.10M to $14.86B, an increase of 11,877.57%. That is a compound annual growth rate of 18.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 14.86B | 5.11% |
| Dec 31, 2025 | 14.14B | 2.32% |
| Dec 31, 2024 | 13.82B | 6.76% |
| Dec 29, 2023 | 12.95B | 12.74% |
| Dec 30, 2022 | 11.48B | 42.11% |
| Dec 31, 2021 | 8.08B | -9.78% |
| Dec 31, 2020 | 8.96B | -9.54% |
| Dec 31, 2019 | 9.90B | 52.87% |
| Dec 31, 2018 | 6.48B | -5.69% |
| Dec 29, 2017 | 6.87B | 104.24% |
| Dec 30, 2016 | 3.36B | -31.05% |
| Dec 31, 2015 | 4.88B | 187.17% |
| Dec 31, 2014 | 1.70B | 169.95% |
| Dec 31, 2013 | 629.00M | 26.66% |
| Dec 31, 2012 | 496.60M | 5.73% |
| Dec 30, 2011 | 469.70M | 12.07% |
| Dec 31, 2010 | 419.10M | 293.15% |
| Dec 31, 2009 | 106.60M | -13.68% |
| Dec 31, 2008 | 123.50M | -28.41% |
| Dec 31, 2007 | 172.50M | -56.31% |
| Dec 29, 2006 | 394.80M | -82.96% |
| Dec 30, 2005 | 2.32B | 28.86% |
| Dec 31, 2004 | 1.80B | -6.54% |
| Dec 31, 2003 | 1.92B | 37.67% |
| Dec 31, 2002 | 1.40B | 3.88% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zoetis | 29.50B |
| United Therapeutics | 21.22B |
| Viatris | 19.47B |
| Elanco Animal Health | 11.20B |
| Dr. Reddy's Laboratories | 10.17B |
| Alkermes | 7.28B |
| Lantheus Holdings | 6.56B |
| Hims & Hers Health | 6.53B |